Seoul, South Korea

Mi-Na Kweon

USPTO Granted Patents = 2 

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mi-Na Kweon: Innovator in Immune Response Formulation

Introduction

Mi-Na Kweon is an accomplished inventor based in Seoul, South Korea, recognized for his significant contributions to the field of immunology. With a total of two patents to his name, Kweon has been instrumental in developing innovative solutions aimed at enhancing immune responses against various microbial infections.

Latest Patents

Kweon's latest patents focus on a combination adjuvant formulation designed to improve immune responses to selected antigens. The described methods and compositions are particularly useful in the treatment and prevention of infections caused by bacteria, viruses, fungi, and parasites. These formulations incorporate host defense peptides, polyphosphazenes, and immunostimulatory sequences, collectively enhancing the immune response to coadministered antigens.

Career Highlights

Mi-Na Kweon's career includes significant tenures at esteemed educational institutions. He has worked at the University of Saskatchewan and Dalhousie University, where he has contributed his expertise in immunology and vaccine development.

Collaborations

Throughout his career, Kweon has collaborated with notable colleagues, including Volker Gerdts and Andrew A. Potter. These partnerships have facilitated the advancement of his research and the successful development of his patented innovations.

Conclusion

In summary, Mi-Na Kweon stands out as a pioneering inventor in the realm of immune response enhancement. His innovative patents and collaborative efforts reflect his commitment to advancing medical science and improving health outcomes through effective microbial infection prevention and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…